Success Metrics

Clinical Success Rate
63.6%

Based on 7 completed trials

Completion Rate
64%(7/11)
Active Trials
2(13%)
Results Posted
57%(4 trials)
Terminated
4(25%)

Phase Distribution

Ph phase_1
2
13%
Ph phase_3
1
6%
Ph not_applicable
3
19%
Ph phase_4
8
50%

Phase Distribution

2

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
8(57.1%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

63.6%

7 of 11 finished

Non-Completion Rate

36.4%

4 ended early

Currently Active

2

trials recruiting

Total Trials

16

all time

Status Distribution
Active(4)
Completed(7)
Terminated(4)
Other(1)

Detailed Status

Completed7
Terminated4
Recruiting2
Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
2
Success Rate
63.6%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 31 (7.1%)
Phase 48 (57.1%)
N/A3 (21.4%)

Trials by Status

unknown16%
recruiting213%
terminated425%
completed744%
not_yet_recruiting213%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT07512635Phase 4

Effect of Intercostal Nerve Block With Liposomal Bupivacaine on Quality of Recovery in VATS Partial Pneumonectomy

Not Yet Recruiting
NCT04272086Phase 4

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

Completed
NCT05992896Phase 4

A Study of Loco-Regional Liposomal Bupivacaine Injection

Terminated
NCT06452147Not Applicable

Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)

Recruiting
NCT06653621Phase 4

Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement

Not Yet Recruiting
NCT03638960Phase 4

Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

Completed
NCT06288841Not Applicable

Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study

Recruiting
NCT03502018Phase 4

Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty

Completed
NCT04685421Phase 1

Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery

Terminated
NCT02517905Phase 3

Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction

Completed
NCT03642457Phase 4

Efficacy Between Serratus Plane Block And Local Infiltration In Vats

Terminated
NCT03526419

Exparel PK and Breast Milk Excretion

Completed
NCT03638635Phase 4

Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients

Terminated
NCT03560362Phase 1

Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

Unknown
NCT03253198Not Applicable

Prospective RCT Comparing Perioperative Pain

Completed
NCT03341104

Evaluation of LB in THA

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16